IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Stock Information for Issuer Direct Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Issuer Direct Corporation

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market
IMAC Holdings Annual Meeting of Shareholders Reminder
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BACK, GNL, RTL

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.